Comparison between effect of low-power laser therapy versus local methylprednisolone injection on plantar fascitis in patients refer to Rheumatology clinic
- Conditions
- Plantar fasciitis.Plantar fasciitis
- Registration Number
- IRCT201110247877N1
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Background: Plantar fasciitis accounts for 11 to 15 percent of foot pain in adults. Although<br /> an injection of corticosteroids is a common treatment in plantar fasciitis, it has side effects<br /> and short-term pain relief. Therefore, this study aimed to compare the effect of low-power<br /> laser therapy (LPLT) with methylprednisolone injection in unilateral plantar fasciitis<br /> patients.<br /> Materials and Methods: In this clinical trial study, 40 patients with unilateral plantar<br /> fasciitis were randomly allocated into two groups (n=20). In the first group, 40 mg of<br /> prednisolone was locally injected and the second group received LPLT in 10 sessions.<br /> Levels of pain and morning stiffness were evaluated.<br /> Results: Forty-two percent of cases were male and 57.5% female. Fifty-five percent of the<br /> patients had right and 45% had left foot fasciitis. The mean age of the patients was 52.98<br /> years and the disease duration was 32.38 weeks. In men pain was seen more in the right foot<br /> and in women in left foot. Duration of pain in women with plantar fasciitis was more than<br /> the men. The effect of the two therapies on morning stiffness and pain reduction was the<br /> same in both groups. Moreover, pain reduction measured by visual analogue scale had a<br /> similar effect during the study in both groups.<br /> Conclusion: LPLT like corticosteroid injection has significant effect on the intensity and<br /> duration of pain and morning stiffness in plantar fasciitis and can be used as an alternative to<br /> corticosteroid injection.<br /> Keywords: Plantar fasciitis, Low-power laser, Local corticosteroid injection
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
patients have 22-65 years with unilateral plantar fascitis and duration of pain more than 6 week ,
Exclusion criteria:patients with bilateral Plantar fascitis; there was history of recent trauma or foot surgery; enrolled during recent 3-6 months therapeutic protocol; there was a previous diagnosis of rheumatoid arthritis; seronegative spondyloarthropathy; cacaneal stress fracture, osteomyelitis; plantar fascia neoplasm and plantar aponeurosis rupture
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The heel pain. Timepoint: After a night of rest and 6 weeks after treatment - after an active day and 6 weeks after treatment. Method of measurement: Visual analog scale.;Tenderness on the junction of plantar fascia. Timepoint: One and six weeks after treatment. Method of measurement: Visual analog scale.
- Secondary Outcome Measures
Name Time Method Infection at injection site. Timepoint: One and six weeks after injection. Method of measurement: Physical examination.